700 studies found for:    Uterine Cancer: Clinical Trials
Show Display Options
Rank Status Study
21 Completed Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
Conditions: Ovarian Neoplasms;   Uterine Neoplasms
Intervention: Drug: Topotecan and Taxotere
22 Recruiting Intravenous Paclitaxel and Intraperitoneal Carboplatin Followed By Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer
Conditions: Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IIIA Endometrial Carcinoma;   Stage IIIB Endometrial Carcinoma;   Stage IIIC Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
23 Active, not recruiting Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Intervention: Drug: pazopanib hydrochloride
24 Terminated Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Condition: Sarcoma
Intervention: Drug: paclitaxel
25 Terminated Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Condition: Sarcoma
Intervention: Drug: gemcitabine hydrochloride
26 Completed Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: imatinib mesylate;   Other: laboratory biomarker analysis
27 Completed Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: ifosfamide;   Drug: paclitaxel
28 Terminated A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers
Condition: Uterine Cancer
Intervention: Drug: Celecoxib
29 Completed A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
Condition: Uterine Cancer
Interventions: Drug: Carboplatin and Paclitaxel and Pelvic Radiation Therapy;   Procedure: Carboplatin and Paclitaxel and Pelvic Radiation Therapy;   Drug: Carboplatin and Paclitaxel and Radiation Therapy
30 Completed Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Conditions: Leiomyosarcoma;   Uterine Neoplasm
Intervention: Drug: gemcitabine, docetaxel, doxorubicin
31 Active, not recruiting Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Pulmonary Carcinoid Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Renal Cell Cancer;   Recurrent Uterine Sarcoma;   Stage III Renal Cell Cancer;   Stage IIIB Uterine Sarcoma;   Stage IIIC Uterine Sarcoma;   Stage IV Renal Cell Cancer;   Stage IVA Uterine Sarcoma;   Stage IVB Uterine Sarcoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: trebananib;   Drug: temsirolimus;   Other: pharmacological study;   Other: laboratory biomarker analysis
32 Completed Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix
Conditions: Uterine Cervical Dysplasia;   Uterine Cervical Intraepithelial Neoplasia;   Uterine Cervical Neoplasia;   Uterine Cervical Cancer
Intervention:
33 Enrolling by invitation Evaluation of Long-term HPV Vaccine Efficacy
Condition: Uterine Cervical Cancer
Intervention: Procedure: Screening for cervical cancer
34 Active, not recruiting Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
Conditions: Anxiety Disorder;   Worry;   Uncertainty;   Sleep Disorders;   Insomnia;   Fatigue;   Pain;   Depression;   Cognitive-behavioral Therapy;   Psychological Intervention;   Esophageal Cancer;   Pancreatic Cancer;   Leukemia;   Lung Cancer;   Multiple Myeloma;   Ovarian Neoplasm;   Stage III or IV Cervical or Uterine Cancer;   Stage IIIB, IIIC, or IV Breast Cancer;   Glioblastoma Multiforme;   Relapsed Lymphoma;   Stage III or IV Colorectal Cancer;   Stage IIIC or IV Melanoma
Intervention: Behavioral: Cognitive-behavioral therapy for worry, uncertainty & insomnia
35 Recruiting Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers
Conditions: Mixed Muellerian Cancer;   Cervical Cancer;   Ovarian Cancer;   Breast Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer;   Endometrial Cancer;   Carcinosarcoma
Interventions: Drug: Carboplatin;   Drug: Olaparib
36 Recruiting Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Conditions: Ovarian Cancer;   Cervical Cancer;   Uterine Cancer;   Anemia
Interventions: Other: Oral Ferrous Fumarate;   Other: Placebo
37 Withdrawn BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
Condition: Endometrial Cancer
Intervention: Drug: BEZ235
38 Recruiting A Multicenter Trial of Benefits of Adding Post-surgery Chemotherapy for Cervical Cancer
Condition: Cervical Cancer
Interventions: Radiation: Radiotherapy;   Drug: Cisplatin;   Drug: Paclitaxel+Cisplatin
39 Completed Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors
Conditions: Cervical Cancer;   Endometrial Cancer;   Ovarian Epithelial Cancer;   Ovarian Germ Cell Tumor;   Uterine Sarcoma;   Vulvar Cancer
Interventions: Other: questionnaire administration;   Procedure: standard follow-up care;   Other: educational intervention
40 Active, not recruiting Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Extensive Stage Small Cell Lung Cancer;   Hereditary Paraganglioma;   Male Breast Cancer;   Malignant Paraganglioma;   Metastatic Gastrointestinal Carcinoid Tumor;   Metastatic Pheochromocytoma;   Pancreatic Polypeptide Tumor;   Recurrent Breast Cancer;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Neuroendocrine Carcinoma of the Skin;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Pheochromocytoma;   Recurrent Prostate Cancer;   Recurrent Renal Cell Cancer;   Recurrent Small Cell Lung Cancer;   Recurrent Uterine Sarcoma;   Regional Gastrointestinal Carcinoid Tumor;   Regional Pheochromocytoma;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage III Neuroendocrine Carcinoma of the Skin;   Stage III Ovarian Epithelial Cancer;   Stage III Ovarian Germ Cell Tumor;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer;   Stage III Uterine Sarcoma;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Endometrial Carcinoma;   Stage IV Neuroendocrine Carcinoma of the Skin;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Prostate Cancer;   Stage IV Renal Cell Cancer;   Stage IV Uterine Sarcoma;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer;   Thyroid Gland Medullary Carcinoma
Interventions: Drug: temsirolimus;   Drug: vinorelbine ditartrate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years